| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.08 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |